寻花楼楼凤兼职论坛-风楼阁交友平台,风楼阁全国官方,400元快餐不限次数qq

ÄãºÃ£¬»¶Ó­À´µ½Î¬¶ÈÅ®ÐÔÍø

ά¶ÈÅ®ÐÔÍø > ʱÉÐÍÆ¼ö > Therasicence¿¹Ë¥ÀÏϵÁÐ

Therasicence¿¹Ë¥ÀÏϵÁÐ

À´Ô´ÓÚ£ºÎ´Öª2021-08-14 19:26±à¼­£ºhuman
·ÖÏí:

 £¨±¾ÎÄËùÓÐÒýÓÃÊý¾ÝºÍÎÄÏ×ÔÚÎÄÕºóÃæ±ê³ö£©

ÓÉÓڸ߾»ÖµÈËȺ½ü20Äê¶ÔÑÓ³¤ÉúÃüÒÔ¼°¾«Á¦ÌåÁ¦²»¶ÏµÄÒªÇó£¬TherascienceµÂŵº£¿ÆµÄÃ÷ÐÇ¿¹Ë¥ÀÏϵÁÐCELLSSENTIEL 2020ÄêÉý¼¶³ÉΪCELLEXTENSE ²»¶ÏÑз¢À©³äϵÁУ¬Ä¿Ç°°üº¬10¿î²úÆ·£¬ÆäÖиù¾Ýŵ±´¶û½±µÄNADH+»¹Ô­ÐÍÑÌõ£°·ÏÙàÑßʶþºËÜÕËá, PQQ(õ«ßÁ¿©²¢à­ßø),ÊÇ´óÖÚÊìÖªµÄÃ÷ÐDzúÆ·£¬Õë¶Ô¹ú¼ÊÊг¡µÄNMN¡£

µÂŵº£¿ÆTherascience×ܲ¿Î»ÓÚ·¨¹úÄϲ¿½ÓÈÀµÄĦÄɸçMonaco£¬ÊÇÈ«Çò¸»È˼¯ÖеĹú¼Ò£¬Á¬Ðø¶àÄê·¿²ú³¬¹ýÖйúÏã¸Û£¬ÈðÊ¿ÈÕÄÚÍß¼Û¸ñÈ«Çò²õÁªµÚÒ»£¬¹«Ë¾³ÉÁ¢22Ä꣬²úÆ·Å·Ö޸߱ê×¼ÖÆÔ죬´¿ÌìÈ»£¬°²È«£¬Ã÷ÏÔµÄЧ¹ûµÃµ½ÁËÅ·ÖÞ·¨ÓïÇø¸ß¾»ÖµÈËȺµÄÇàíù£¨Ä¦Äɸ磬·¨¹ú£¬Â¬É­±¤£¬ÈðÊ¿£¬±ÈÀûʱ£©£¬±»ÓþΪ±£½¡Æ·ÀàµÄ“ÉÝ³ÞÆ·ÅÆ”¡£

һȺÈËÔŲ́ÉÏÑݽ²ÃèÊöÒÑ×Ô¶¯Éú³É

µÂŵº£¿ÆTherascienceÊ×ϯ¿ÆÑ§¼ÒAnne-Marie ROUSSEL ÔÚ¹ú¼ÊÂÛ̳½²Êö²úÆ·»úÀí

ͼƬ°üº¬ ÊÒÄÚ, ÈË, Ì컨°å, ×À×ÓÃèÊöÒÑ×Ô¶¯Éú³É

Anne Marie ROUSSELÔÚѧÊõ»áÒéÉϽâÊͲúÆ·»úÀíÒÔ¼°³É·ÝÅä±È

¿¹Ë¥»úÀí

´Óŵ±´¶û, Ë¥Àϵķ¢Õ¹¹ý³ÌÓëÏßÁ£Ì幦ÄÜÒì³£ÓÐÃÜÇйØÏµ¡£ÔÚË¥ÀϹý³ÌÖÐ, ÏßÁ£ÌåÉúÎïѧ·¢Éú±ä»¯, ÏßÁ£Ìå²úÉú×ÔÓÉ»ùºÍ×ÔÓÉ»ù¶ÔÏßÁ£ÌåµÄËðÉ˶ÔË¥Àϵķ¢Õ¹Æðµ½´Ù½ø×÷ÓÃ; ÏßÁ£Ìå DNA Í»±äºÍÏßÁ£Ìå¶Ôϸ°ûËÀÍö½ø³ÌµÄµ÷¿ØÓëË¥ÀϵĽø³ÌÓÐÃÜÇйØÏµ¡£ ÏßÁ£ÌåÊÇϸ°ûÓÐÑõºôÎüºÍºÏ³ÉÈýÁ×ËáÏÙÜÕ£¨ATP£©µÄÖ÷Òª³¡Ëù£¬ÎªÏ¸°ûµÄ»î¶¯ÌṩÁË»¯Ñ§ÄÜÁ¿£¬ËùÒÔÓГϸ°ûµÄ·¢µçÕ¾”Ö®³Æ¡£³ýÁËΪϸ°û¹©ÄÜÍ⣬ÏßÁ£Ì廹²ÎÓëÖîÈçϸ°û·Ö»¯¡¢Ï¸°ûÐÅÏ¢´«µÝºÍϸ°ûµòÍöµÈ¹ý³Ì£¬²¢ÓµÓе÷¿ØÏ¸°ûÉú³¤ºÍϸ°ûÖÜÆÚµÄÄÜÁ¦¡£

ͼƬ°üº¬ ÓÎÏ·»ú

ÃèÊöÒÑ×Ô¶¯Éú³É

Ë¥ÀϰéËæ×ÅËùÓÐ×éÖ¯ÖÐÏßÁ£Ì幦ÄܵįձéϽµ£¬ÏßÁ£ÌåÊÜËð£¬ÉíÌåºÍÉñ¾­ÏµÍ³¶¼»áÊܵ½²»Í¬³Ì¶ÈµÄÓ°Ï죬Ö÷Òª±íÏÖΪ£ºÆ¤·ôËɳÚ¡¢ÍÑ·¢¡¢¾«Á¦²»¼Ã¡¢¼ÇÒäÁ¦Ë¥ÍË¡¢Ê§Ãߵȣ¬ÉõÖÁµ¼ÖÂÉñ¾­ÍËÐÐÐÔ¼²²¡¡£

¿ÆÑ§¼Ò·¢ÏÖ£¬ÓÐÒ»ÖÖ±»³ÆÎªÏßÁ£ÌåËØNADHµÄÎïÖÊ£¨»¯Ñ§Ãû³Æ£º»¹Ô­ÐÍÑÌõ£°·ÏÙàÑßʶþºËÜÕËᣩËüÊÇ´æÔÚÓÚÈËÌåϸ°ûÄÚÒ»ÖÖÉúÎïÐÎʽµÄÇâ¡£NADH½øÈëÌåÄÚºóÄܹ»¸ßЧ·Ö½âΪNAD+ºÍÇ⣬ÕâÑù¼ÈÌáÉýÁËNAD+ˮƽ£¬ÇâÒ²ÕýÊÇÄܹ»¸ßЧÇå³ý×ÔÓÉ»ùµÄ×îÀíÏëÎïÖÊ¡£ÖйúÖøÃûºôÎü²¡Ñ§×¨¼Ò¡¢Öйú¹¤³ÌԺԺʿÖÓÄÏÉ½ÔøËµ£º“¼øÓÚÇâ·Ö×Ó¾ßÓкÜÇ¿µÄ¿¹Ñõ»¯×÷Óã¬ÌرðÆä¸ßÑ¡ÔñÐÔ£¨½öÖкͶ¾ÐÔ»îÐÔÑõ×ÔÓÉ»ù£©¡¢¸ßÃÖÉ¢ÐԺ͸߰²È«ÐÔ£¬Òò´ËÊܵ½¹ã·ºÖØÊÓ”

Ö»ÒªÌá¸ßÁËϸ°ûÖÐÏßÁ£ÌåËØNADHµÄº¬Á¿£¬Ï¸°û¾ÍÄÜÉú²ú×ã¹»µÄ¡¢ÉúÃüËù±ØÐëµÄÄÜÁ¿£¬½ø¶ø¿ÉÒÔ¸üºÃ·¢»Óϸ°ûµÄ¸÷ÏÄÜ¡£

ÐÄÔàºÍ´óÄÔÊÇËùÓÐÆ÷¹ÙÖÐ×îÐèÒªÏßÁ£ÌåËØNADHµÄ£¬ËùÒÔÕâЩÆ÷¹Ùͨ¹ýÍâÔ´²¹³äÏßÁ£ÌåËØNADH»ñµÃµÄÊÕÒæ×î¶à¡£ÆäËûÆ÷¹Ù£¬ÌرðÊǷΡ¢¸Î¡¢ÉöµÈ£¬Ò²ÒªÍ¨¹ý²¹³äÏßÁ£ÌåËØNADH´Ó¶ø»ñÈ¡½Ï¶àÄÜÁ¿£¬²ÅÄܸüºÃµÄ·¢»Ó¹¦ÄÜ¡£

ͼƬ°üº¬ ÓÎÏ·»ú, ÎÄ×Ö

ÃèÊöÒÑ×Ô¶¯Éú³É

·þÓÃNADHºó£¬ÌåÄÚNAD+µÄˮƽ

NAD+ÊÇϸ°ûÖк¬Á¿×î·á¸»µÄ¸¨Ã¸£¬¶øNADH×÷ΪËüµÄ»¹Ô­ÐÎʽ¡£ÔÚºôÎü×÷ÓÃÖУ¬ÔÚÌǽͽâ¡¢ÈýôÈËáÑ­»·¹ý³ÌÖÐÓÉNAD+²úÉúNADH£¬¶øÔÚÑõ»¯Á×Ëữ¹ý³ÌÖУ¬NADHÊͷųöÖÊ×Ӻ͵ç×Ó£¬ÌṩÄÜÁ¿ºÏ³ÉATP£¬²¢×ÔÉí±»Ñõ»¯ÎªNAD+¡£

ͼƬ°üº¬ ÓÎÏ·»ú

ÃèÊöÒÑ×Ô¶¯Éú³É

ÊÀ½çÉÏ×îÔçµÄ¹ú¼Ê¶¥¼¶Ñ§Êõ¿¯ÎïÖ®Ò»¡¶×ÔÈ»¡·£¨Nature£©ÔÓÖ¾ÔÚ2019Äê10Ô¿¯µÇÁËÒ»·Ý×îÐÂÑо¿£¬½éÉÜÁËŵ¼ÓÒò×ÓNADH¶Ô¼²²¡¸ÉÔ¤Ó뿹˥¹¦Ð§µÄ¿ÆÆÕ¡£NAD+ ºÍNADH £¬ NADHÊÇNAD+µÄ»¹Ô­Ì¬£¬Ö±½Ó²ÎÓëÏßÁ£ÌåATPµÄÄÜÁ¿ºÏ³É¡£1Á£NADH+½ºÄÒ´óÔ¼Ï൱ÓÚ4Á£NMN½ºÄÒ£¬ÕâÒ²ÊÇNMNΪʲôÆÕ±é¼ÆÁ¿Òª´óÓÚNADH+,ÒòΪÔÚÎüÊÕºÍת»¯ÖÐÈÝÒ×Á÷ʧ¡£

ͼƬ°üº¬ ÓÎÏ·»ú, ÖÓ±í

ÃèÊöÒÑ×Ô¶¯Éú³É

ÊÖ»úÆÁÄ»µÄ½ØÍ¼

ÃèÊöÒÑ×Ô¶¯Éú³É

NADH¶Ô¹âÏßºÍ¿ÕÆøÀïµÄË®·ÖÌØ±ðÃô¸Ð¡£¶øÇÒÔÚ½øÈëθ²¿ºó¼«Ò×±»½µ½â£¬¼«²»Îȶ¨¡£ÓÉÓÚÉϸöÊÀ¼ÍµÄ¼¼ÊõÌõ¼þÉÐδ´ïµ½£¬´ó¶àÊýÉñ¾­ÍËÐÐÐÔ¼²²¡»¼Õß¶¼ÊÇͨ¹ý×¢ÉäµÄ·½Ê½½øÐÐÖÎÁÆ¡£µÂŵº£¿ÆÊµÑéÊÒTherascienceµÄÃ÷ÐDzúÆ·NADH+²úƷרÀû¼¼Êõ£¬ÒÔ¼°´´Ðµķ´Ê½½ºÄÒ¼¼Êõ£¬±£Ö¤²»ÊÜθËáÓ°Ï죬ÏÔʾ³öζȺÍÒ×ÎüÊÕµÄÌØÐÔ¡£Õâ¿î²úÆ·²»½öº¬ÓÐŵ½±»ñµÃÕßÑÇɪ・¹þ

ºÍ±È¿ËÂó¶û½ÌÊÚ²»Ð¸Å¬Á¦µÄ³É¹ûNADH£¬»¹º¬ÓÐάÉúËØB1¡£NADH´Ì¼¤Éñ¾­µÝÖʵÄ×Ô¶¯ºÏ³É£¬ÓëάÉúËØB1µÄЭͬ×÷ÓãºÇ¿»¯Éñ¾­ÏµÍ³£¬µ÷½ÚѹÁ¦£¬¼¯ÖÐ×¢ÒâÁ¦£¬ÔöÇ¿¼ÇÒäÁ¦¡£ÄÜÓÐЧԤ·ÀÓÉË¥ÀÏÉñ¾­ÍËÐÐÐÔ¼²²¡

Æ¿×ÓÉÏд×Å×Ö

ÃèÊöÒÑ×Ô¶¯Éú³É

¡¶Cell¡·ºÍ¡¶Nature¡·ÉϵĴóÁ¿Ñо¿·¢ÏÖ£ºNMNÄÜÓÐЧÑÓ»ºË¥ÀÏÒýÆðµÄ¸÷ÖÖÎÊÌâ¡£¹þ·ðҽѧԺµÄÑо¿·¢ÏÖNMN¿ÉÒÔ»º½âË¥ÀÏ¡£

Therascience NMN²úÆ·ÊǸù¾Ý¹þ·ðҽѧԺ½ÌÊÚ·½°¸Ìṩ200mg + 50 mg °×޼«´¼¡£

NMN½øÈëÌåÄÚ±ä³ÉNAD+ºó¶ÔÄÜÁ¿ºÍÎïÖÊ´úл²úÉúÖØÒª×÷Ó᣽ö¾ÍÈýôÈËáÑ­»·¶øÑÔ£¬ÈýôÈËáÑ­»·ÊÇÈËÌåÈý´óÓªÑø£¨ÌÇÀà¡¢Ö¬Àà¡¢°±»ùËᣩµÄ*ÖÕ´úлͨ·£¬Ò²ÊÇÌÇÀà¡¢Ö¬ÀàºÍ°±»ùËá´úлÁªÏµµÄÊàŦ£¬ÈýôÈËáÑ­»·Í¬Ê±ÎªÓлúÌåÌṩÁË´óÁ¿ÄÜÁ¿ÊÇÓлúÌåÄÜÁ¿ÊàŦ¡£ÏßÁ£ÌåÄڵĸ¨Ã¸I£¨NAD£©ÔÚTCAÑ­»·ÖнÓÊܵç×Ó´«µÝ»¹Ô­³É»¹Ô­Ð͸¨Ã¸I(NADH)£¬1 mol¸¨Ã¸I(NAD)¿ÉÒÔÉú³É3 mol ATP£¬ÊÇϸ°ûÉúÃü»î¶¯ÄÜÁ¿µÄÖØÒªÀ´Ô´¡£

ͼƬ°üº¬ ÓÎÏ·»ú, ÈéÒº

ÃèÊöÒÑ×Ô¶¯Éú³É

õ«ßÁ¿©²¢à­ßø×÷ΪÈËÀàÓªÑøÖÐÒ»ÖÖÖ÷ÒªµÄÑõ»¯»¹Ô­¸¨Òò×Ó£¬PQQÓëϸ°ûÖеĵ°°×Ïà½áºÏ£¬²¢Æðµ½¿¹Ñõ»¯¼ÁµÄ×÷Óá£PQQÒÔ¼¤»îÏßÁ£ÌåÉúÎïÆðÔ´Ñõ»¯´úлÖеÄÊý¸öÐźÅͨ·£¬´Ì¼¤Ï¸°ûÉú³¤Óë·Ö»¯¶øÖø³Æ¡£

ÖÚ¶à¹ú¼ÊÐÔÑо¿±íÃ÷£¬PQQ¶Ô²»Í¬²¿Î»¶¼Æð±£»¤×÷ÓãºÈËÌåϸ°ûÄÚµÄÏßÁ£Ìå,ÓÐÑõ»¯ÐÔËðÉ˵ÄÉñ¾­Ôª,²úÉúȱѪÐÔËðÉ˵ÄÐļ¡¿ÉÒÔºÍNADH+¹²Í¬Ê¹Óá£

Æ¿×ÓÉÏд×Å×Ö

ÃèÊöÒÑ×Ô¶¯Éú³É

CELL-SSENTIEL®ÏµÁÐ Protect+. ϸ°û¿¹Ñõ»¯+

¸ßŨËõÂ̲è¶à·Ó¡¢·´Ê½°×޼«´¼ ¡¢ÁòÐÁËá ¡¢Îø ¡¢Ð¿¡¢Î¬ÉúËØB×塢άÉúËØC¡¢ÌìȻάÉúËØD3¡¢ÌìȻάÉúËØE

ͼƬ°üº¬ ÓÎÏ·»ú

ÃèÊöÒÑ×Ô¶¯Éú³É

GH-natÊõºó»Ö¸´

È˲ÎÔíÜÕ¡¢ L-¾«°±Ëá¡¢L Àµ°±Ëá¡¢L-Äñ°±Ëáα-ͪÎì¶þËá¡¢L-¹Ï°±Ëá¡¢Ö§Á´°±»ùËá¡¢¸Æ¡¢Ð¿¡¢Î¬ÉúËØB×塢άÉúËØD3

´Ù½øÑªÒºÑ­»·£¬Ëõ¶Ì¿µ¸´Ê±¼ä£¬¸ÄÉÆ¿µ¸´Ð§¹û£¬·ÀÖ¹¼¡ÈâήËõ£¬ÔöÇ¿µÖ¿¹Á¦

Æ¿×Ó·ÅÔÚÒ»Æð

ÃèÊöÒÑ×Ô¶¯Éú³É

·´Ê½°×޼«´¼

ÌìÈ»·¢½Í98%Ìá´¿µÄ·´Ê½°×޼«´¼150.0 mg

ÌìȻάÉúËØE 10.0 mg

Æ¿×ÓÉÏд×Å×Ö

ÃèÊöÒÑ×Ô¶¯Éú³É

ϺÇàËØ

ÌìȻϺÇàËØ8.0mg¡¢ÌìȻάÉúËØE 1.8 mg

ÎÄÏ××ÊÁÏ£º

1.Nuo Sun, Richard J. Youle, Toren Finkel, Mitochondrial Theory of Aging and Other Aging Theories. Mol Cell. 2016 Mar 3; 61(5): 654–666Ë¥ÀϵÄÏßÁ£Ìå»ù´¡

2.Birkmayer G. Nadh: The Energizing Coenzyme. McGraw Hill Professional, 1998  Nadh£ºÔö¼Ó»îÁ¦µÄ¸¨Ã¸

3.Birkmayer. JGD. Coenzym-1 (NADH) – Eine wissenschaftlich bewiesene Anti-Aging-Substanz. Prevention and anti aging 2006: 340-348. »¹Ô­Ð͸¨Ã¸I£¨NADH£©£º¾­¹ý¿ÆÑ§Ö¤Ã÷µÄ¿¹Ë¥ÀÏÎïÖÊ

4.Nadlinger K, Westerthaler W, Storga-Tomic D, Birkmayer JGD. Extracellular metabolization of NADH by blood cells correlated with intracellular ATP levels. Biophys. Biochim Acta 2002; 1573: 177-182. Ѫϸ°û¶ÔNADHµÄϸ°ûÍâ´úлÓëϸ°ûÄÚATPˮƽÏà¹Ø

5.Zhu K(1), Swanson RA, Ying W. NADH can enter into astrocytes and block poly(ADP-ribose) polymerase-1-mediated astrocyte death. Neuroreport. 2005 Aug 1;16(11):1209-12. NADH¿ÉÒÔ½øÈëÐÇÐνºÖÊϸ°û²¢×è¶Ï¾Û£¨ADP-ºËÌÇ£©¾ÛºÏø1½éµ¼µÄÐÇÐνºÖÊϸ°ûËÀÍö

6.Demarin V, Podobnik-Sarkanji S, Storga-Tomic D, Kay G,  Martinic-Popovic,M. Puretic B., Birkmayer JGD. ENADA/NADH improves cognitive impairment of Alzheimer patients. J. Tumor Marker Oncology 2003; 18:43-49. ENADA / NADH¿É¸ÄÉÆ°¢¶û´Äº£Ä¬ÊÏÖ¢»¼ÕßµÄÈÏÖªÕϰ­

7.Reibnegger G, Greilberger J, Juergens G. and Oettl K. The antioxidative capacity of ENADA®-NADH in humans. J. Tumor Marker Oncol. 2003; 18, 37-41. ENADA®-NADHÔÚÈËÌåÄڵĿ¹Ñõ»¯ÄÜÁ¦

8.Lotfi R, Birkmayer J, Ghouni A, Metabolic and Anthropometric Effects of NADH RAPID Energy in Diabetic Type 2. Journal of Food Science and Engineering 6 (2016) 280-285. NADH RAPIDÄÜÁ¿ÔÚ2ÐÍÌÇÄò²¡»¼ÕßÖеĴúлºÍÈËÌå²âÁ¿×÷ÓÃ

9.Birkmayer JGD, Vrecko C, Volc D, Birkmayer W.Nicotinamide adenine dinucleotide (NADH) – a new therapeutic approach to Parkinson’s disease: Comparison of oral and parenteral application. Acta Neurol Scand. 1993; 87: 32-35. »¹Ô­ÐÍÑÌõ£°·ÏÙàÑßʶþºËÜÕËᣨNADH£©-ÅÁ½ðÉ­Êϲ¡µÄÐÂÖÎÁÆ·½·¨£º¿Ú·þºÍ³¦Î¸ÍâÓ¦ÓõıȽÏ

10.Birkmayer JGD, Zhang JR, ed. Bagchi D, Preuss H. NADH in Cancer Prevention and Therapy. CRC Press 2005; chapter 33, 541- 554. NADHÔÚ°©Ö¢µÄÔ¤·ÀºÍÖÎÁÆÖеÄÓ¦ÓÃ

11.Grathwohl D, Klann M, Müller HM, Schlachter H, Berg A. Influence of NADH supplementation for the muscular energy supply in humans. Deutsche Zeitschrift für Sportmedizin, 11/2000. ²¹³äNADH¶ÔÈËÀ༡ÈâÄÜÁ¿¹©Ó¦µÄÓ°Ïì

12.Kay GG, Virre ES, Moline M. Stabilized NADH (ENADA) as Counter-Measure Jet Lag and Sleep Deprivation. J. Tumor Marker Oncol. 2001; 16 : 124-125. Îȶ¨µÄNADH£¨ENADA£©×÷ΪӦ¶Ôʱ²îºÍ˯Ãß²»×ãµÄ´ëÊ©

13.³ÂÓÀºì, ¶Å¹Ú»ª. ÏßÁ£ÌåÓëË¥ÀÏ. ÖйúÒ©Àíѧͨ±¨ Chinese Pharmacological Bulletin 2000 Dec; 16( 5) : 485~ 

Ö£ÖØÉùÃ÷£º´ËÎÄÄÚÈÝΪ±¾ÍøÕ¾¿¯·¢»ò×ªÔØ£¬½öΪÐû´«¼°´«µÝ¸ü¶àÐÅϢ֮ĿµÄ£¬ÎÄÕÂÕæÊµÐÔÇëä¯ÀÀÕßÉ÷ÖØºËʵ£¡Èç¹ûÓÐÇÖ·¸ÄúȨÀûµÄ×ÊÔ´£¬Çë¸æÖª£¬ÎÒÃǽ«¼°Ê±É¾³ý¡£ÁªÏµÓÊÏä:edit#vdolady.com
    Ïà¹ØÔĶÁ

    ÈÈÃŹؼü´Ê

    Ù»±ÌС·½¿ÚºìÏÞÁ¿°æ  Ñƹâ¿ÚºìÄÄ¿îºÃ  Í¿¿Úºì»á¿¨´½ÎÆÔõô°ì  ÏãÄζùϸ¹Ü¿Úºì202  ÏãÄζù±±¼«Ðܿں젠ysl¿ÚºìÖйú°æºÍ¹úÍâ°æ  Ê¥ÂÞÀ¼¿Úºì12ºÅ¼¸¿Ë¼¸¿Ë  ¿Úºì´øÁÁ¾§¾§µÄ·ÛÄ©  mac¿Úºìa97ÊÇÄĸöÉ«ºÅ  v¿ªÍ·µÄ¿ÚºìÆ·ÅÆ  ½ÓÎÇǰ²Á¿Úºì  ×ì´½ºÜ±¡ÊʺÏÄÄ¿î¿Úºì  ¼ÍèóÏ£¹ÙÍø¿Úºì332  ÉÏ´½Ì«ºñÔõôͿ¿Úºì  ÑÅÊ«À¼÷ì¿Úºì301ÊÔÉ«  »Ø¹úÄÜ´ø¼¸Ö»¿Úºì  Å®ÍõȨÕȿںìΪʲô¹ó  Í¿¿Úºì  ×öÑǹâ¿Úºì¼Ó¶àÉÙË¿ÈÞ·Û  ¹þ¶û±õÄÄÀïÂòÊ¥ÂÞÀ¼¿Úºì  ¿ÚºìÔÚ¶à¸ßµÄζȻữ  ³¬×ÌÈóÐͿںìÓÐÄÄЩ  ÄĸöÅÆ×ÓÓÐÎ÷¹Ïºì¿Úºì  ¿ÚºìË¿ÈáÎíÃæÑÆ¹âʲôÒâ˼  Å·À³Ñſںì603  green¿ÚºìÊÇÊ²Ã´Æ·ÅÆ  mac¿ÚºìºÍÅ·À³ÑſںìÄĸöºÃ  ¿ÚºìÔÚÃâ˰µê±Èר¹ñ±ãÒ˶àÉÙ  ×ÔÖÆ¿ÚºìÍÑĤΪʲô»á¶Ï  ¿ÚºìÂòÊ²Ã´ÅÆ×ÓµÄ×îºÃ  mac¿Úºìplumful  µÏ°Âºì¹Ü¿Úºì555  ¿ÚºìµþͿ˳ÐòÉîdz  °¢Àï°Í°ÍÉÏmac¿ÚºìÊÇÕæµÄÂð  ¿ÚºìºÍ´½ÓÔÄĸöÄÍÓà ÈçºÎÕýȷͿĨ¿Úºì  Í¿¿Úºìǰ´òµ×µÄ½Ðʲô  È¥×¨¹ñÔõôÊԿں첻Âò  À¼Þ¢ 181ºÅ¿ÚºìÑÕÉ«  °¢ÂêÄá¿ÚºìÄÄ¿î×î»ð  À¼Þ¢ÎíÃæ¿Úºì157  °´Ñ¹¿Úºìµ¯»É×°Öà Ãµ¹å»¨×ÔÖÆëÙÖ¬¿Úºì  ¿ÚºìÔõôͿ²Å±¥Âú  mac¿Úºìµ×±êÓм¸ÖÖ  Í¿ÉÏÑÆ¹â¿Úºìºó¿´ÆðÀ´ºÜ¸É  ¿ÚºìÅÅÃûÓëÆä³É·Ö  µÏ°Âר¹ñÂò¿ÚºìËÍÀñºÐÂð  ´½ÓÔ¿ÉÒԸijɿںìÂð  ³ÔÁ˿ںì»á²»»áÓÐÊ  iroha¿ÚºìСºìÊé  ×Öĸm¿ªÊ¼µÄ¿Úºì  tf¿Úºì44ºÅÊÇʲôÑÕÉ«  ´ºÌìÏÄÌìͿʲôÑÕÉ«µÄ¿Úºì  Öйú·ç¿ÚºìÆ·ÅÆ¹ú²ú  ysl¿Úºì20Ö§ÀñºÐÌ××°  Í¿¿Úºì˵»°¶àÁËÓа×Ó¡  Ð¡³û¾ÕÈùºì¿ÉÒÔÓÃÀ´×ö¿ÚºìÂð  tf¿Úºì´ú¹º´ó¸Å¶àÉÙÇ®  µÏ°Â¿Úºì665¼Û¸ñ  éÙɫϵ¿ÚºìÑÕÉ«´óÈ«  ËÍÒ»Ö§¿ÚºìµÄ×£¸£Óï  200¶àµÄ¿ÚºìµÄÅÆ×Ó  nars¿Úºì8215  ÓÃË®¹û×ö¿Úºì  Í¿¿Úºì×ìÉÏÕ³ð¤µÄ½ºÖÊ  ½ÓÎÇÓпںìÔõô°ì  ÍõÕßÈÙÒ«mac¿ÚºìÄР ¿ÚºìԤıɫ  mac¿Úºìº¬Ç¦Á¿³¬±ê  ysl¿ÚºìÈÝÒ×»¯Âð  ¿ÚºìÓÐÈ󴽸àµÄ×÷ÓÃÂï  ¼ÍèóÏ£Ìì¶ìÈ޿ں젠ÍêÃÀÈռǿںìs02  µÏ°Â°¢ÂêÄáÊ¥ÂÞÀ¼¿ÚºìÄĸö¹ó  Ä¨¿ÚºìΪʲôÏÈÍ¿´½¸à  cpb¿Úºì313ÊÔÉ«  Íâ¹úÆ·ÅÆ¿Úºì´óÈ«  ¿ÚºìÍѵ×ÁËÔõô°ì  tf¿Úºì¶àÉÙÇ®